
Werewolf Therapeutics, Inc. Common Stock Share Price
NASDAQ: HOWLHealthcare
Live Werewolf Therapeutics, Inc. Common Stock Share Price Chart
O H L
Werewolf Therapeutics, Inc. Common Stock Performance Overview
Days Range
▼
$0.91Low
$0.92High
Markets Today
| Previous Close | $0.92 |
|---|---|
| Open | $0.91 |
| Volume | 192,047 |
| Day's Range | $0.91 - $0.92 |
| 52W Range | $0.27 - $2.15 |
| Market Cap | $45.20 M |
Historical Performance
| 1M Returns | -6.10 |
|---|---|
| 3M Returns | +167.50 |
| 6M Returns | -7.98 |
| 1Y Returns | -52.32 |
| 5Y Returns | -94.50 |
| 10Y Returns | NA |
Werewolf Therapeutics, Inc. Common Stock Fundamentals
| Market Cap | $45.20 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -1.24 |
| EPS TTM | $-0.73 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 2.77 |
| EBITDA | $-59.04 M |
| Profit Margin | N/A |
| Market Cap | $45.20 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -1.24 |
| EPS TTM | $-0.73 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 2.77 |
| EBITDA | $-59.04 M |
| Profit Margin | N/A |
Werewolf Therapeutics, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $0 | $0 | $0 | $0 | $0 | $21.00 M |
| Gross Profit + | $0 | $0 | $0 | $0 | $0 | $21.00 M |
| Operating Income | -$17.99 M | -$17.54 M | -$15.73 M | -$9.42 M | -$13.27 M | $7.16 M |
| EBITDA | -$17.57 M | -$17.14 M | -$15.32 M | -$9.02 M | -$12.87 M | $9.61 M |
| Interest Expense | -$1.26 M | -$1.30 M | -$1.34 M | -$1.37 M | -$1.37 M | -$475.00 K |
| Depreciation | $426.00 K | $406.00 K | $402.00 K | $400.00 K | $398.00 K | $2.45 M |
| Income Before Tax | -$18.09 M | -$17.98 M | -$16.37 M | -$8.38 M | -$13.53 M | $3.67 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$18.09 M | -$17.98 M | -$16.37 M | -$8.38 M | -$13.53 M | $3.67 M |
| Net Profit Margin | - | - | - | - | - | 17.48% |
Werewolf Therapeutics, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $5.00 K | $5.00 K | $5.00 K | $5.00 K | $5.00 K | $5.00 K |
| Reserve & Surplus | -$432.68 M | -$450.66 M | -$467.03 M | -$475.41 M | -$488.94 M | -$485.27 M |
| Non-Current Liabilities | $38.26 M | $35.93 M | $32.41 M | $8.44 M | $7.30 M | $0 |
| Current Liabilities | $11.67 M | $15.17 M | $17.60 M | $36.15 M | $38.52 M | $7.86 M |
| Total Liabilities | $49.93 M | $51.10 M | $50.01 M | $44.59 M | $45.82 M | $7.86 M |
| Fixed Assets | $5.90 M | $5.49 M | $5.09 M | $4.69 M | $4.29 M | $1.26 M |
| Current Assets | $94.46 M | $80.44 M | $68.17 M | $58.59 M | $48.73 M | $22.89 M |
| Total Assets | $107.24 M | $92.57 M | $79.63 M | $69.40 M | $58.02 M | $24.16 M |
Werewolf Therapeutics, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$18.09 M | -$17.98 M | -$16.37 M | -$8.38 M | -$13.53 M | $3.67 M |
| Operating Cash Flow | -$18.95 M | -$15.16 M | -$15.16 M | -$11.02 M | -$10.60 M | $6.63 M |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $0 | $416.00 K |
| Financing Cash Flow | $0 | $388.00 K | $3.27 M | $2.37 M | $0 | -$32.41 M |
| Change in Cash | -$18.95 M | -$14.78 M | -$11.88 M | -$8.66 M | -$10.60 M | -$25.37 M |
Werewolf Therapeutics, Inc. Common Stock Return Calculator
The Werewolf Therapeutics, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$544
Invested Amount$10,000
Est. Returns$-9,456
About Werewolf Therapeutics, Inc. Common Stock
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.
Popular Stocks
FAQs
What is the share price of Werewolf Therapeutics, Inc. Common Stock today?
Werewolf Therapeutics, Inc. Common Stock (HOWL) share price as of October 7, 2026 is $0.91. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Werewolf Therapeutics, Inc. Common Stock?
Yes, Indian Investors can invest in the Werewolf Therapeutics, Inc. Common Stock (HOWL) Share by opening an international trading account with Angel One.
How can I purchase Werewolf Therapeutics, Inc. Common Stock shares in India?
Purchasing Werewolf Therapeutics, Inc. Common Stock (HOWL) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Werewolf Therapeutics, Inc. Common Stock (HOWL) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Werewolf Therapeutics, Inc. Common Stock?
Yes, you can purchase fractional shares of Werewolf Therapeutics, Inc. Common Stock (HOWL) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Werewolf Therapeutics, Inc. Common Stock?
The market capitalization of Werewolf Therapeutics, Inc. Common Stock on October 7, 2026, is $45.20 M.
In which sector Werewolf Therapeutics, Inc. Common Stock belongs?
Werewolf Therapeutics, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Werewolf Therapeutics, Inc. Common Stock stocks?
In order to invest in Werewolf Therapeutics, Inc. Common Stock (HOWL) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
